1. Home
  2. GGB vs GKOS Comparison

GGB vs GKOS Comparison

Compare GGB & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gerdau S.A.

GGB

Gerdau S.A.

SELL

Current Price

$5.02

Market Cap

8.8B

Sector

Industrials

ML Signal

SELL

Logo Glaukos Corporation

GKOS

Glaukos Corporation

SELL

Current Price

$164.00

Market Cap

9.7B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
GGB
GKOS
Founded
1901
1998
Country
Brazil
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
9.7B
IPO Year
2000
2015

Fundamental Metrics

Financial Performance
Metric
GGB
GKOS
Price
$5.02
$164.00
Analyst Decision
Buy
Strong Buy
Analyst Count
5
14
Target Price
$5.76
★ $199.31
AVG Volume (30 Days)
★ 11.9M
927.3K
Earning Date
10-26-2026
10-28-2026
Dividend Yield
★ 2.59%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $507,442,000.00
Revenue This Year
$1.24
$36.30
Revenue Next Year
$3.35
$23.25
P/E Ratio
$13.89
★ N/A
Revenue Growth
N/A
★ 32.33
52 Week Low
$3.14
$73.16
52 Week High
$5.48
$191.62

Technical Indicators

Market Signals
Indicator
GGB
GKOS
Relative Strength Index (RSI) 51.28 48.63
Support Level $4.86 $147.72
Resistance Level $5.18 $186.99
Average True Range (ATR) 0.15 7.39
MACD 0.00 0.80
Stochastic Oscillator 44.71 64.90

Price Performance

Historical Comparison
GGB
GKOS

About GGB Gerdau S.A.

Gerdau SA produces steel and steel products. The company operates in civil construction, agriculture, automotive, iron ore, exports, research and development, and home steel products sectors. It offers products such as Semi-finished products (Billets, Blooms and Slabs), Special bar quality, Common Long Rolled Products, Dawn products, Merchant bar, Beams, Rebar, Piling, Iron Ore and Others. The company's geographical segment includes Brazil Segment; North America Segment; and South America Segment. It derives the majority of its revenue from the Brazil Operations segment, which includes the long, flat and special steel operations and the iron ore operation located in Brazil and joint ventures and associated companies located in Brazil.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: